Company Profile (AI Text)
Name: Stapgen LLC
Canonical URL: https://wefunder.com/stapgen.llc
Updated at: 2026-06-14T05:03:10Z

Tagline: We aim to prevent T2DM prior to the rise of blood sugar. 
Elevator pitch: We will manufacture, distribute, and sell STAP-test, and biologics for detection and treatment of incipient Diabetes for both Human, and animals.

Key claims:
- Total raised on Wefunder: 62686 | citation: https://wefunder.com/stapgen.llc#claim-total-raised
- Total investors: 54 | citation: https://wefunder.com/stapgen.llc#claim-total-investors

Verified facts:
- Total raised on Wefunder: 62686 | observed_at: 2026-06-14T05:03:10Z | expires_at: 2026-06-15T05:03:10Z
- Total investors: 54 | observed_at: 2026-06-14T05:03:10Z | expires_at: 2026-06-15T05:03:10Z

Computed metrics:
- total_amount_raised: 62686
- total_investors: 54
- team_size: 2
- featured_investor_count: 1
- faq_count: 2
- recent_post_count: 0

Quick facts:
- Patented STAP-Test may detect and provide risk of developing Type 2 Diabetes 5 years in advance | citation: https://wefunder.com/stapgen.llc#claim-fact-1
- Few other companies in USA can detect and intercept developing T2DM prior to the rise of blood sugar | citation: https://wefunder.com/stapgen.llc#claim-fact-2
- Dr. MS Malo dedicated over 40 years in the field of Medicine and Biotech and have 7 patents | citation: https://wefunder.com/stapgen.llc#claim-fact-3
- 6.7 million death attributed to diabetes world-wide in 2021 according to IDF | citation: https://wefunder.com/stapgen.llc#claim-fact-4
- Stapgen's mission is to save about 80% of those untimely, and unwanted deaths (not guaranteed) | citation: https://wefunder.com/stapgen.llc#claim-fact-5
- We believe Stapgen is one of the only companies licensed for the device world-wide | citation: https://wefunder.com/stapgen.llc#claim-fact-6

FAQ:
- Q: Is $85K the total raise you are seeking, or is that just an initial goal of some type?
  A: Thanks for the question. $85K is just an initial goal. It will help to build the foundation of the company including lab, and FDA communication. More capital needed to fulfill the requirements of FDA and commercialization of the test.
- Q: Too expensive valuation for the stage of the project and risk level. Can you please clarify. If it's 20m at this stage what do you expect the valuation at future fundraise.
  A: STAPGEN round is closed for now. Will keep you posted for the next round. Valuation for this round should have been minimum 100 million. Thanks for your interest.